ENSIGN GROUP, INC ENSG

Healthcare SIC 8051 - Services-Skilled Nursing Care Facilities NAICS Health Care and Social Assistance › Nursing and Residential Care Facilities derived Nasdaq

Founded in 1999, The Ensign Group, Inc. (Ensign) is a holding company with independent subsidiaries that provide skilled nursing, senior living and rehabilitative services, as well as other ancillary businesses (including mobile diagnostics and medical transportation), in 17 states. As part of our investment strategy, we also acquire, lease and own healthcare real estate to service the post-acute care continuum through acquisition and investment opportunities in healthcare properties. For the year ended December 31, 2025, we generated approximately 95.6% of our revenue from our skilled nursing facilities. The remainder of our revenue is primarily generated from our real estate properties, senior living services and other ancillary services.

Last close 175.59 2026-10-23
Market cap $10.23B 2026-06-30 share count
52-week range 141.58 - 218.00

Valuation FY2025 figures against the last close

P/S2.0x
P/E30.1x
P/FCF18.1x
EV/EBITDA18.5x
Dividend yield0.1%
Diluted EPS5.84

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $5.03B$4.24B$3.71B$3.03B$2.63B$2.39B$2.04B$1.75B$1.60B$1.65B
Cost of revenue $4.02B$3.38B$2.94B$2.35B$2.02B$1.87B$1.62B$1.42B$1.31B$1.34B
Gross profit $1.01B$860.6M$766.8M$671.0M$607.6M$522.2M$415.9M$336.4M$284.9M$313.1M
SG&A $269.8M$225.1M$263.0M$158.8M$151.8M$129.7M$110.9M$90.6M$74.1M$69.2M
Total operating expenses $4.63B$3.90B$3.47B$2.73B$2.37B$2.18B$1.91B$1.67B$1.56B$1.56B
Operating income $425.3M$358.3M$255.4M$296.8M$260.5M$223.2M$129.2M$84.9M$43.2M$91.8M
Interest expense $8.0M$8.3M$8.1M$8.9M$6.8M$9.4M$15.7M$15.2M$13.6M$7.1M
Pre-tax income $455.6M$386.1M$272.8M$289.1M$258.0M$217.6M$116.2M$71.7M$31.2M$85.8M
Income tax $111.4M$87.6M$62.9M$64.4M$60.3M$46.2M$24.0M$12.7M$14.2M$33.0M
Net income $344.0M$298.0M$209.4M$224.7M$194.7M$170.5M$110.5M$92.4M$40.5M$50.0M
EPS, basic 6.005.263.764.093.573.192.071.780.790.99
EPS, diluted 5.845.123.653.953.423.061.971.700.770.96
Shares, diluted (wtd. avg.) 58.9M58.2M57.3M56.9M56.9M55.8M56.0M54.4M52.8M52.1M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $503.9M$464.6M$509.6M$316.3M$262.2M$236.6M$59.2M$31.0M$42.3M$57.7M
Short-term investments $68.5M$62.3M$17.2M$15.4M$13.8M$13.4M$17.8M$8.7M$13.1M$11.6M
Receivables $637.0M$569.9M$485.0M$408.4M$328.7M$305.1M$309.0M$251.9M$265.1M$244.4M
Total current assets $1.27B$1.16B$1.05B$781.1M$639.7M$583.0M$411.1M$348.1M$368.1M$333.9M
Property, plant and equipment $1.70B$1.29B$1.09B$992.0M$888.4M$778.2M$767.6M$608.4M$537.1M$484.5M
Goodwill $98.0M$98.0M$76.9M$76.9M$60.5M$54.5M$54.5M$49.6M$53.1M$46.0M
Other intangibles $6.4M$7.3M$6.5M$6.4M$2.7M$2.9M$3.4M$30.9M$32.8M$35.1M
Total assets $5.46B$4.67B$4.18B$3.45B$2.85B$2.55B$2.36B$1.18B$1.10B$1.00B
Accounts payable $97.3M$98.9M$92.8M$77.1M$58.1M$50.9M$45.0M$39.8M$39.0M$39.0M
Short-term debt $4.2M$4.1M$4.0M$3.9M$3.8M$3.0M$2.7M$10.1M$9.9M$8.1M
Total current liabilities $894.3M$743.4M$734.7M$582.1M$523.1M$562.4M$343.2M$269.2M$225.8M$211.9M
Long-term debt $137.5M$141.6M$145.5M$149.3M$152.9M$117.6M$330.4M$233.1M$303.0M$275.5M
Total liabilities $3.23B$2.83B$2.68B$2.20B$1.83B$1.73B$1.71B$579.6M$602.4M$540.5M
Retained earnings $1.76B$1.43B$1.14B$946.3M$734.0M$551.1M$391.5M$344.9M$264.7M$235.0M
Total equity $2.23B$1.84B$1.50B$1.25B$1.02B$818.2M$656.1M$602.3M$500.1M$460.5M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $564.3M$347.2M$376.7M$272.5M$275.7M$373.4M$192.2M$210.3M$79.5M$73.9M
Depreciation and amortisation $104.3M$84.1M$72.4M$62.4M$56.0M$54.6M$51.1M$44.9M$42.3M$38.7M
Stock-based compensation $48.3M$36.2M$30.8M$22.7M$18.7M$14.5M$11.3M$8.4M$7.8M$9.1M
Capital expenditure ——————$71.5M$50.9M$54.1M$65.7M
Investing cash flow -$513.2M-$390.1M-$182.7M-$186.2M-$173.9M-$58.7M-$247.0M-$151.2M-$113.2M-$210.6M
Financing cash flow -$11.8M-$2.2M-$612.0K-$32.3M-$76.1M-$137.3M$82.9M-$70.3M$18.3M$152.9M
Dividends paid $14.4M$13.7M$12.9M$12.2M$11.5M$10.8M$10.2M$9.4M$8.7M$8.2M
Buybacks $20.0M$0$0$29.9M$10.1M$25.0M$6.4M$0$7.3M$30.0M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001125376-26-000007.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. 0 2B 4B 6B Revenue, FY2016: 1.7B Gross profit, FY2016: 313.1M Net income, FY2016: 50M Revenue, FY2017: 1.6B Gross profit, FY2017: 284.9M Net income, FY2017: 40.5M Revenue, FY2018: 1.8B Gross profit, FY2018: 336.4M Net income, FY2018: 92.4M Revenue, FY2019: 2B Gross profit, FY2019: 415.9M Net income, FY2019: 110.5M Revenue, FY2020: 2.4B Gross profit, FY2020: 522.2M Net income, FY2020: 170.5M Revenue, FY2021: 2.6B Gross profit, FY2021: 607.6M Net income, FY2021: 194.7M Revenue, FY2022: 3B Gross profit, FY2022: 671M Net income, FY2022: 224.7M Revenue, FY2023: 3.7B Gross profit, FY2023: 766.8M Net income, FY2023: 209.4M Revenue, FY2024: 4.2B Gross profit, FY2024: 860.6M Net income, FY2024: 298M Revenue, FY2025: 5B Gross profit, FY2025: 1B Net income, FY2025: 344M FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $1.65B $1.60B $1.75B $2.04B $2.39B $2.63B $3.03B $3.71B $4.24B $5.03B
Gross profit $313.1M $284.9M $336.4M $415.9M $522.2M $607.6M $671.0M $766.8M $860.6M $1.01B
Net income $50.0M $40.5M $92.4M $110.5M $170.5M $194.7M $224.7M $209.4M $298.0M $344.0M

Recent filings and events

  • Charter or fiscal year changed A change to the company's governing documents, or to when its year ends. Item 5.03
  • Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
  • New debt or obligation The company has taken on debt or a comparable obligation. Item 2.03
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
  • Other event Item 8.01
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Results announced Item 2.02
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Results announced Item 2.02
  • Results announced Item 2.02

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 8051

TickerCompanyMarket capP/ERevenue growth
PACS PACS Group, Inc. $7.54B 39.0x 29.4%
NHC NATIONAL HEALTHCARE CORP $3.70B 30.8x 17.4%